AN2 Therapeutics, Inc.

ANTX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$21,351$15,647$27,219$12,097
Short-Term Investments$62,267$91,648$68,840$46,458
Receivables$300$1,400$0$0
Inventory$0$0$0$0
Other Curr. Assets$2,344$1,812$2,562$1,551
Total Curr. Assets$86,262$110,507$98,621$60,106
Property Plant & Equip (Net)$0$0$53$0
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$5,021$27,194$3,219$3,486
Tax Assets$0$0$0$0
Other NC Assets$804$1,043$667$1,724
Total NC Assets$5,825$28,237$3,939$5,210
Other Assets$0$0$0$0
Total Assets$92,087$138,744$102,560$65,316
Liabilities
Payables$3,317$2,676$2,122$1,063
Short-Term Debt$0$0$53$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$6,921$11,367$5,011$2,332
Total Curr. Liab.$10,238$14,043$7,186$3,395
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$2$13
Total NC Liab.$0$0$2$13
Other Liabilities$0$0$0$0
Cap. Leases$0$0$53$0
Total Liabilities$10,238$14,043$7,188$3,408
Equity
Pref Stock$0$0$0$109,319
Common Stock$0$0$0$0
Retained Earnings-$205,776-$154,455-$89,723-$47,384
AOCI$31$275-$374-$27
Other Equity$287,594$278,881$185,469$0
Total Equity$81,849$124,701$95,372$61,908
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$92,087$138,744$102,560$65,316
Net Debt-$21,351-$15,647-$27,166-$12,097